» Articles » PMID: 33710394

Exome Sequencing Reveals Predominantly De Novo Variants in Disorders with Intellectual Disability (ID) in the Founder Population of Finland

Abstract

The genetics of autosomal recessive intellectual disability (ARID) has mainly been studied in consanguineous families, however, founder populations may also be of interest to study intellectual disability (ID) and the contribution of ARID. Here, we used a genotype-driven approach to study the genetic landscape of ID in the founder population of Finland. A total of 39 families with syndromic and non-syndromic ID were analyzed using exome sequencing, which revealed a variant in a known ID gene in 27 families. Notably, 75% of these variants in known ID genes were de novo or suspected de novo (64% autosomal dominant; 11% X-linked) and 25% were inherited (14% autosomal recessive; 7% X-linked; and 4% autosomal dominant). A dual molecular diagnosis was suggested in two families (5%). Via additional analysis and molecular testing, we identified three cases with an abnormal molecular karyotype, including chr21q22.12q22.2 uniparental disomy with a mosaic interstitial 2.7 Mb deletion covering DYRK1A and KCNJ6. Overall, a pathogenic or likely pathogenic variant was identified in 64% (25/39) of the families. Last, we report an alternate inheritance model for 3 known ID genes (UBA7, DDX47, DHX58) and discuss potential candidate genes for ID, including SYPL1 and ERGIC3 with homozygous founder variants and de novo variants in POLR2F and DNAH3. In summary, similar to other European populations, de novo variants were the most common variants underlying ID in the studied Finnish population, with limited contribution of ARID to ID etiology, though mainly driven by founder and potential founder variation in the latter case.

Citing Articles

Deciphering the genetic basis of developmental language disorder in children without intellectual disability, autism or apraxia of speech.

Ormieres C, Lesieur-Sebellin M, Siquier-Pernet K, Delplancq G, Rio M, Parisot M Mol Autism. 2025; 16(1):10.

PMID: 39948625 PMC: 11823097. DOI: 10.1186/s13229-025-00642-8.


Clinical characteristics of patients with variant-associated epilepsy and therapeutic exploration: a case report and literature review.

Wang Y, Li S, Hu W, Zhao L, Lan M, Chen J Front Neurol. 2024; 15:1428076.

PMID: 39582684 PMC: 11581967. DOI: 10.3389/fneur.2024.1428076.


Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay.

Li C, Wang Y, Zeng C, Huang B, Chen Y, Xue C Sci Rep. 2024; 14(1):27590.

PMID: 39528574 PMC: 11555314. DOI: 10.1038/s41598-024-79431-x.


Genome Sequencing Identifies 13 Novel Candidate Risk Genes for Autism Spectrum Disorder in a Qatari Cohort.

Ben-Mahmoud A, Gupta V, Abdelaleem A, Thompson R, Aden A, Mbarek H Int J Mol Sci. 2024; 25(21).

PMID: 39519104 PMC: 11547081. DOI: 10.3390/ijms252111551.


A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons.

Carter J, Halmai J, Waldo J, Vij P, Anguiano M, Villegas I Stem Cells. 2024; 43(1).

PMID: 39460716 PMC: 11811633. DOI: 10.1093/stmcls/sxae068.


References
1.
Anazi S, Maddirevula S, Faqeih E, Alsedairy H, Alzahrani F, Shamseldin H . Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry. 2016; 22(4):615-624. DOI: 10.1038/mp.2016.113. View

2.
Bibel M, Barde Y . Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000; 14(23):2919-37. DOI: 10.1101/gad.841400. View

3.
Hou Y, Wu K, Shi X, Li F, Song L, Wu H . Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing. Gigascience. 2015; 4:37. PMC: 4527218. DOI: 10.1186/s13742-015-0068-3. View

4.
Cheng S, Chan K, Leung K, Au P, Tam W, Li S . Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong. Am J Med Genet C Semin Med Genet. 2019; 181(2):196-207. DOI: 10.1002/ajmg.c.31697. View

5.
de Brouwer A, Yntema H, Kleefstra T, Lugtenberg D, Oudakker A, de Vries B . Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum Mutat. 2007; 28(2):207-8. DOI: 10.1002/humu.9482. View